On the other hands, in Alzheimer’s disease, Acetylcholinesterase (AChE) inhibitors prevent neurodegeneration and the manufacture of reactive oxygen species (ROS) in brain cells. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.